Clinical Trial

Accuracy of a Cuffless Photoplethysmography (PPG) Chest-Patch Monitor for 24-hour Ambulatory Blood Pressure Monitoring (ABPM)

Study acronym: PPG ABPM
Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to validate the accuracy and reliability of blood pressure (BP) estimates obtained over 24 hours using a PPG-based chest-patch device compared to the gold standard ambulatory blood pressure monitoring (ABPM) method using an upper arm cuff-based oscillometric BP device, in both hypertensive and normotensive individuals referred by their provider to undergo a 24-hours ABPM for clinical indication. The Awake/Asleep test, which is the primary test recommended for automated wearable cuffless BP devices that are cuff-calibrated (based on the 2023 European Society of Hypertension (ESH) recommendations for the validation of cuffless blood pressure measuring devices), will be conducted in this study. The secondary aim of the study is to assess the feasibility and convenience of the PPG-based device.
Protocol Amendment History 1 change
notable Trial sites expanded: 5 -> 10 locations 2026-05-14
Trial Details
NCT Number NCT07240831
Lead Sponsor Biobeat Technologies Ltd.
Collaborators: Mayo Clinic
Conditions Blood Pressure, Heart Disease, Hypertension (HTN), Blood Pressure Monitoring
Enrollment 600 participants
Start Date 2025-12-15
Primary Completion 2026-10-30 (estimated)
Study Completion 2026-10-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-13